Company Performance Metrics
- Fabian Gerlinghaus: Co-Founder and CEOPast Role: Synthego, Chief Innovation Officer
- Ali Soleymannezhad: Chief Commercial OfficerPast Role: MaxCyte, Chief Commercial Officer
Cellares develops and operates integrated technologies for automated cell therapy manufacturing and quality control that help biopharmaceutical partners scale development to industrial production. The company’s offerings include the Cell Shuttle platform for end-to-end automation of the cell therapy manufacturing process and the Cell Q platform for
automated quality control, supported by integrated software and consumable cartridges. Cellares positions itself as an Integrated Development and Manufacturing Organization that supports process transfer, scalable production, and regulatory pathways for clinical and commercial programs. Its services enable clients to transition manual processes onto automated systems and expand manufacturing capacity to meet broader patient demand.